top of page
New_logo.png

 Where little things make a big difference

  • Twitter
  • LinkedIn

About the company

Nanobiosym Diagnostics (NBSDx) focuses on the commercialization of the Gene-RADAR, a portable nanotechnology platform that can rapidly and accurately detect genetic fingerprints from any biological organism, empowering people worldwide with rapid, affordable, and portable diagnostic information about their own health.

Leadership Team

1516255843600.jpeg

Dr Anita Goel

Chairman and CEO

  • LinkedIn

Company Details

Founded in:

Industry:

2004

Genetics

Country:

UN SDGs:

USA

3, 9

Technology

Focus:

Nanotechnology

Stage:

Grant | Alive

Revenue

Stage:

Generating Revenue

Investment

Raised:

$100K

Investment Raised From

Grant • July 10, 2020

$0.1M / Investor: Unreasonable Group

*Source: CB Insights

Angel • Feb 26, 2015

Investor: Paul Maritz

*Source: CB Insights

Recent Media Coverage

bottom of page